Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China flag China · Delayed Price · Currency is CNY
26.99
-0.56 (-2.03%)
Sep 10, 2026, 2:34 PM CST

SHA:600976 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
164.57113.71163.17305.12219.33301.66
Short-Term Investments
210.17136.51----
Trading Asset Securities
877.71954.14954.19694.46641.38538.63
Cash & Short-Term Investments
1,2521,2041,117999.58860.71840.28
Cash Growth
18.30%7.79%11.78%16.13%2.43%45.64%
Accounts Receivable
1,1141,040957.561,150868.66674.6
Other Receivables
37.9123.825.7631.4349.6421.43
Receivables
1,1521,164983.331,181918.29696.03
Inventory
312.2286.57354.31450.85362.88222.6
Other Current Assets
89.7694.89146.43134.06162.85104.5
Total Current Assets
2,8072,7502,6012,7662,3051,863
Property, Plant & Equipment
679.57698.07595.59450.7417.65396.65
Long-Term Investments
689.49722.3772.18650.42444.94326.85
Goodwill
0.210.210.210.210.210.21
Other Intangible Assets
26.0927.5328.1928.8731.1632.98
Long-Term Deferred Tax Assets
179.36180.34129.49139.44117.27118.33
Long-Term Deferred Charges
133.66136.33130.78111.2791.6687.64
Other Long-Term Assets
11.1812.1619.7421.1432.5630.01
Total Assets
4,5264,5274,2784,1683,4402,856

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
649.72642.52742.22782.91611.06374.92
Accrued Expenses
739.91716.3574.78724.73620.32592.57
Short-Term Debt
2055.05140.979.4522.5245
Current Portion of Leases
6.665.626.395.127.346.1
Current Income Taxes Payable
100.21104.0552.7466.2349.6871.75
Current Unearned Revenue
30.0936.1961.4341.1982.5237.04
Other Current Liabilities
156.18176.11166.66157.31140.25191.85
Total Current Liabilities
1,7031,7361,7451,8571,5341,319
Long-Term Debt
33.8634.034---
Long-Term Leases
33.3931.0324.4330.2923.4820.37
Long-Term Unearned Revenue
37.2144.4146.5518.6112.1827.72
Long-Term Deferred Tax Liabilities
4.784.87.25.625.970.84
Total Liabilities
1,8121,8501,8271,9111,5751,368

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
153.4153.4153.4153.4153.4153.4
Additional Paid-In Capital
522.73522.73523.42520.68509.17421.5
Retained Earnings
2,0191,9801,7581,5801,212931.06
Treasury Stock
----6.76-14.99-25.08
Total Common Equity
2,6962,6562,4352,2481,8601,481
Minority Interest
18.2220.415.038.784.997.04
Shareholders' Equity
2,7142,6772,4502,2561,8651,488
Total Liabilities & Equity
4,5264,5274,2784,1683,4402,856

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
94.25125.73175.71114.8653.3471.48
Net Cash (Debt)
1,1581,079941.65884.72807.37768.81
Net Cash Growth
22.94%14.55%6.44%9.58%5.02%38.07%
Net Cash Per Share
7.627.106.195.795.305.06
Filing Date Shares Outstanding
153.4153.4153.4153.82152.78151.97
Total Common Shares Outstanding
153.4153.4153.4153.82152.78151.97
Working Capital
1,1031,014856.33908.95771.06544.18
Book Value Per Share
17.5717.3215.8814.6112.179.74
Tangible Book Value
2,6692,6292,4072,2191,8291,448
Tangible Book Value Per Share
17.4017.1415.6914.4211.979.53
Buildings
404.46409.52287.12284.12289.38298.05
Machinery
489.12485.88314.22312.36301.9251.25
Construction In Progress
43.6540.17206.6841.4817.1916.73